| |
Newsroom /
Health and Fitness
/
Health and Fitness
/
EMR Releases a New Series of Reports on Key Developed Erectile Dysfunction Drug Markets
EMR Releases a New Series of Reports on Key Developed Erectile Dysfunction Drug Markets
EMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key developed erectile dysfunction markets till 2016.
Noida,
UP,
India
(prbd.net)
23/09/2011
In its new series of reports on the erectile dysfunction market, Expert Market Research, one of the world’s leading providers of lifescience market intelligence, analyses the market potential of erectile dysfunction drugs in key developed markets.
EMR’s erectile dysfunction market series includes reports on the following countries:
• US Erectile Dysfunction Market Report and Forecast: 2011-2016
• UK Erectile Dysfunction Market Report and Forecast: 2011-2016
• Canada Erectile Dysfunction Market Report and Forecast: 2011-2016
• Italy Erectile Dysfunction Market Report and Forecast: 2011-2016
• France Erectile Dysfunction Market Report and Forecast: 2011-2016
• Spain Erectile Dysfunction Market Report and Forecast: 2011-2016
• Germany Erectile Dysfunction Market Report and Forecast: 2011-2016
Each of these reports provide a comprehensive analysis on the current and future market trends in the erectile dysfunction drugs market. These reports also facilitate a deep insight into the current and future epidemiology of erectile dysfunction and its market structure besides probing into the performance of various segments, companies, molecules and brands. These reports can serve as an excellent guide for clients who are in need of an in-depth understanding of the market for erectile dysfunction drugs.
Key Questions Answered in these Reports:
• What is the current and future size of the erectile dysfunction patient population?
• What are the current and future prevalence rates for erectile dysfunction?
• What are the current and future diagnosis rates for erectile dysfunction?
• What are the current and future drug treatment rates for erectile dysfunction?
• What has been the historical performance of the erectile dysfunction market and how will it behave in the coming years?
• Who are the leading companies in the erectile dysfunction market and how will they perform in the coming years?
• What are the leading drugs in the erectile dysfunction market and how will they behave in the coming years?
Why should you buy these Reports?
• To gain an in-depth insight into the prevalence, diagnosis and drug treatment rates for erectile dysfunction
• To have it as a powerful tool for identifying your target patient population.
• To facilitate business decision-making based on historical, current and forecast market data for erectile dysfunction drugs
• To identify potential drugs, partners and competitors so as to develop strategies for market penetration and drug development
• To develop business strategies by looking at companies that have been the biggest winners and losers in the erectile dysfunction market.
• To gain an understanding into future market events and make more informed business decisions.
Research Objectives Achieved in these Reports:
Evaluating the Epidemiology of Erectile Dysfunction:
Key Aspects Analyzed:
• Current and future prevalence of erectile dysfunction
• Current and future size of the erectile dysfunction patient pool
• Current and future size of the diagnosed erectile dysfunction patient pool
• Current and future size of the drug treated erectile dysfunction patient pool
Comprehensive Situation Analysis of the Erectile Dysfunction Market:
Key Aspects Analyzed:
• Historical, current and future market trends
• Historical, current and future performance of various drugs
• Historical, current and future performance of various companies.
• Product portfolio of various companies
• Analysis for pipeline drugs
• Market Forecast
Methodology & Information Sources:
To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K’s, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.
Table of Contents
1. Research Methodology & Definitions
2. Executive Summary
3. Erectile Dysfunction Prevalence & Patient Population
3.1 Prevalence of Erectile Dysfunction
3.2 Erectile Dysfunction Patient Pool
3.3 Diagnosed & Drug Treated Patient Pool
4. The Erectile Dysfunction Drugs Market Landscape
4.1 Current Trends & Forecast
4.1.1 Current Market Trends
4.1.2 Market Forecast
4.2 Performance of Various Players
4.2.1 Historical Performance of Key Players
4.2.2 Product Portfolio of Key Players
4.2.2 Market Forecast of Key Players
4.3 Performance of Various Molecules
4.3.1 Historical Performance of Key Drugs
4.3.2 Analysis of Pipeline Drugs
4.3.2 Market Forecast of Current & Pipeline Drugs
To buy the complete report or to get a free sample:
Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe)
Email: sales@expertmarketresearch.com
To know more please visit: http://www.expertmarketresearch.com
About
Expert Market Research is one of the world’s leading providers of lifescience market intelligence. Our award winning and trusted portfolio of proprietary business solutions have been supporting some of the world’s leading pharmaceutical companies, biotechnology companies, medical device companies, clinical research organizations, contract manufacturers and hospitals for over 6 years. We have helped organizations in achieving peak performance, maintaining their leadership positions and raising th
|